Skip to main content
SpringerLink
Log in

Do we need new trials for the abiraterone, enzalutamide and cabazitaxel in metastatic castrate-resistant prostate cancer for confirmation of treatment indications?

  • Letter to the Editor
  • Published:
World Journal of Urology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. de Bono JS, Oudard S, Ozguroglu M et al (2010) Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 376:1147–1154

    Article  PubMed  Google Scholar 

  2. de Bono JS, Logothetis CJ, Molina A et al (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364:1995–2005

    Article  PubMed  PubMed Central  Google Scholar 

  3. Scher HI, Fizazi K, Saad F et al (2012) Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 367:1187–1197

    Article  CAS  PubMed  Google Scholar 

  4. Loriot Y, Miller K, Sternberg CN et al (2015) Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomised, phase 3 trial. Lancet Oncol 16:509–521

    Article  CAS  PubMed  Google Scholar 

  5. Ryan CJ, Smith MR, de Bono JS et al (2013) Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 368:138–148

    Article  CAS  PubMed  Google Scholar 

  6. Sweeney CJ, Chen YH, Carducci M et al (2015) Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med 373:737–746

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Gravis G, Boher JM, Joly F (2015) Androgen deprivation therapy (ADT) plus docetaxel versus ADT alone for hormone-naïve metastatic prostate cancer: long-term analysis of the GETUG-AFU-15 phase III trial. Proc Am Soc Clin Oncol 33:140

    Article  Google Scholar 

  8. James ND, Sydes MR, Clarke NW et al (2016) Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet 387:1163–1177

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

I would like to thank to 2Professor Ian F. Tannock, MD, PhD, DSc, for revising and commenting on this paper. 2Ian F. Tannock, MD, PhD, DSc, Emeritus Professor of Medical Oncology, Medical Biophysics, Princess Margaret Cacer Centre and University of Toronto.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Izmir University Medical Park Hospital, Izmir, Turkey

    Cagatay Arslan

Authors
  1. Cagatay Arslan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cagatay Arslan.

Ethics declarations

Conflict of interest

The author declare that he has no conflict of interest.

Human and animal rights statement

This study was not done on human being or animals, and for this type of study, formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Arslan, C. Do we need new trials for the abiraterone, enzalutamide and cabazitaxel in metastatic castrate-resistant prostate cancer for confirmation of treatment indications?. World J Urol 35, 479–480 (2017). https://doi.org/10.1007/s00345-016-1895-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-016-1895-2

Keywords

Search

Navigation